Finding 978209 (2023-002)

Significant Deficiency
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2024-06-24
Audit: 309693
Auditor: Bdo

AI Summary

  • Core Issue: PSI's procurement tracking method was incomplete, leading to potential noncompliance with federal procurement standards.
  • Impacted Requirements: Failure to follow documented procurement procedures as per §200.318 and maintain complete records may result in disallowed procurements.
  • Recommended Follow-Up: Management should refine procurement tracking and clarify policies to ensure consistency across all international offices.

Finding Text

2023-002 Internal Control over Compliance and Compliance with Procurement Requirements See Schedule of Findings and Questioned Costs for chart/table. Criteria or Specific Requirement: In accordance with §200.318(a), General Procurement Standards, the non-federal entity must use its own documented procurement procedures which reflect applicable State, local, and tribal laws and regulations, provided the procurements conform to applicable federal law and the standards identified in General Procurement Standards. Additionally, §200.318(i) states that the non-federal entity must maintain records sufficient to detail the history of the procurement. These records are required to include, but are not necessarily limited to the following: rationale for the method of procurement, selection of contract type, contractor selection or rejection, and the basis for the contract price. All procurement transactions must be conducted in a manner providing full and open competition consistent in accordance with §200.319 and must be performed using the appropriate procurement method as outlined in §200.320. Condition: During the audit, we noted PSI management actively works with its country offices to address the importance of tracking transactions using a systematic approach that require procurement procedures to be completed. A purchase order tracking method exists; however, when BDO was provided a listing of procurements that was determined to be incomplete. Management ultimately was able to provide a complete listing after additional investigation and analysis. The direct and pass-through awards listed above were the impacted awards for both major programs. Questioned Costs: There are no questioned costs. Context: This is a condition identified based on our review of the internal control for generating a complete procurement population. The sampling of the compliance area would have been incomplete if BDO utilized the original listing provided by PSI. Cause: PSI personnel did not adhere to PSI’s documented policies and procedures for tracking purchases and ensuring a complete population for testing. Effect: Failure to generate a complete and accurate procurement listing could indicate an issue in which items do not follow the procurement process. Failure to perform procurement procedures in accordance with PSI’s documented policies and Procurement Procedures as outlined in the Uniform Administrative Requirements could result in the procurement being disallowed. Repeat Finding: This is not a repeat finding. Recommendation: We recommend management refine their procurement tracking method by clarifying established policies and procedures to create more consistency across PSI’s international office locations. Views of Responsible Officials: PSI management agrees with the finding and recommendations set forth within and has developed a corrective action plan to address the instances of noncompliance identified and lapses in prescribed internal controls.

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 401766 2023-001
    Significant Deficiency Repeat
  • 401767 2023-002
    Significant Deficiency
  • 401768 2023-004
    Significant Deficiency Repeat
  • 401769 2023-003
    Significant Deficiency Repeat
  • 401770 2023-003
    Significant Deficiency Repeat
  • 401771 2023-002
    Significant Deficiency
  • 401772 2023-003
    Significant Deficiency Repeat
  • 401773 2023-001
    Significant Deficiency Repeat
  • 401774 2023-002
    Significant Deficiency
  • 401775 2023-004
    Significant Deficiency Repeat
  • 401776 2023-005
    Significant Deficiency Repeat
  • 401777 2023-002
    Significant Deficiency
  • 401778 2023-004
    Significant Deficiency Repeat
  • 401779 2023-005
    Significant Deficiency Repeat
  • 401780 2023-002
    Significant Deficiency
  • 401781 2023-004
    Significant Deficiency Repeat
  • 401782 2023-004
    Significant Deficiency Repeat
  • 401783 2023-004
    Significant Deficiency Repeat
  • 401784 2023-003
    Significant Deficiency Repeat
  • 401785 2023-001
    Significant Deficiency Repeat
  • 401786 2023-001
    Significant Deficiency Repeat
  • 978208 2023-001
    Significant Deficiency Repeat
  • 978210 2023-004
    Significant Deficiency Repeat
  • 978211 2023-003
    Significant Deficiency Repeat
  • 978212 2023-003
    Significant Deficiency Repeat
  • 978213 2023-002
    Significant Deficiency
  • 978214 2023-003
    Significant Deficiency Repeat
  • 978215 2023-001
    Significant Deficiency Repeat
  • 978216 2023-002
    Significant Deficiency
  • 978217 2023-004
    Significant Deficiency Repeat
  • 978218 2023-005
    Significant Deficiency Repeat
  • 978219 2023-002
    Significant Deficiency
  • 978220 2023-004
    Significant Deficiency Repeat
  • 978221 2023-005
    Significant Deficiency Repeat
  • 978222 2023-002
    Significant Deficiency
  • 978223 2023-004
    Significant Deficiency Repeat
  • 978224 2023-004
    Significant Deficiency Repeat
  • 978225 2023-004
    Significant Deficiency Repeat
  • 978226 2023-003
    Significant Deficiency Repeat
  • 978227 2023-001
    Significant Deficiency Repeat
  • 978228 2023-001
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
98.U00 Usaid Cost Reimbursable Contracts and Other Awards $8.63M
98.001 Usaid Foreign Assistance for Programs Overseas $6.30M
98.001 Covid 19 - Usaid Foreign Assistance for Programs Overseas $145,831
12.350 Department of Defense Hiv/aids Prevention Program $54,674
93.318 Covid 19 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $-275
93.067 Global Aids $-6,695
98.U00 Covid 19 - Usaid Cost Reimbursable Contracts and Other Awards $-178,808